Management & Key Employees

+ Show All   |   – Hide All

  NASRAT HAKIM    President & Chief Executive Officer

Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership. Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company.

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.

  MARC BREGMAN    Chief Financial Officer

Marc Bregman joined Elite in May of 2021 as Chief Financial Officer. Mr. Bregman has more than 27 years of financial and operational experience, including positions as Controller at Langan Engineering & Environmental Services and Controller at Chemtrade Logistics. He held corporate financial positions at Chemetall and National Starch & Chemical Company and was a supervisor and senior auditor at Ernst & Young.  Mr. Bregman brings experience in financial accounting, financial planning & analysis, governance & compliance, financial auditing, Sarbanes-Oxley Act (SOX) compliance, and cost accounting.

Mr. Bregman has a Bachelor’s degree in Accounting from William Paterson College and a Master of Science in Business degree from the Martin Tuchman School of Management at the New Jersey Institute of Technology. Mr. Bregman is a Certified Public Accountant (CPA).

  G. KENNETH SMITH, J.D., PH.D.    Vice President of Legal

Ken Smith has served as Elite’s Vice President of Legal since October 2014. Prior to joining Elite, Dr. Smith previously held the positions of Chief Intellectual Property Counsel for Alpharma, Inc. and before that Head of North American Intellectual Property for Sanofi Aventis. In both positions, Dr. Smith had global responsibility for all intellectual property issues related to multiple business units involved with various technologies including branded products, animal health products, active pharmaceutical ingredients, generic drugs, and vaccines. Dr. Smith also brings extensive background and knowledge in the area of abuse-deterrent intellectual property. Dr. Smith has a Ph.D. in Biochemistry from the University of Houston, an M.B.A from Lehigh University, and a J.D. from the University of Houston.

  DOUG PLASSCHE    Executive Vice President of Operations

Doug Plassche, a Certified Six Sigma Black Belt, joined Elite in August 2013 and brings with him more than 23 years of pharmaceutical industry experience. From 2009 to 2013, Mr. Plassche was employed by Actavis as Managing Director of the New Jersey Solid Oral Dose Operations, overseeing 450 employees and the production of more than 100 products. From 2007 to 2009, Mr. Plassche was Senior Director of Manufacturing for PAR Pharmaceuticals overseeing 200 employees and the production of more than 70 products. From 1990 – 2007, he was employed by Schering-Plough progressing steadily through multiple disciplines, locations and technical operations sectors with increasing levels of responsibility.

  CHRIS DICK    Head of Development

Chris Dick joined Elite in November 2002 as Vice President of Business Development. Since August 2013, Mr. Dick has served as Head of Development. During his tenure at Elite, Mr. Dick has served in various capacities including Executive Vice President of Corporate Development, President, Chief Operating Officer, acting Chief Executive Officer and Board Director. Prior to joining Elite, Mr. Dick served as Director of Business Development for Elan Drug Delivery, Inc. responsible for licensing and business development of Elan’s portfolio of drug delivery technologies. From 1978 to 1999, he held various business and technical positions at FMC Corporation which included responsibility for business development and marketing for EnTec™, a drug delivery business unit within FMC Corporation’s Pharmaceutical Division, and marketing for its pharmaceutical functional coatings product line. Mr. Dick holds an M.B.A. from the Stern School of Business, New York University, and a B.S. and M.S. in Chemical Engineering from Cornell University.

JASON M. LEPREE, PH.D., R.PH. Vice President of Scientific and Medical Affairs

Jason LePree, Ph.D., R.Ph., is Vice President of Scientific and Medical Affairs. Dr. LePree has over 20 years of pharmaceutical development experience in small, mid-sized, and large branded and generic pharmaceutical companies including scientific leadership positions at Ferring International Pharmaceutical Science Center – US, Gattefossé Corporation, Novartis, and Capsugel. Dr. LePree received his B.S. degree in Pharmacy from Rutgers University and his Doctor of Philosophy degree in Pharmacy (Pharmaceutics) with a minor in Chemistry from the University of Wisconsin-Madison. Dr. LePree has extensive experience in Formulation Development, Materials Characterization, and Analytical Sciences.

WILLIAM SCOTT GRONER VP of Quality & Regulatory Affairs

Scott Groner is Vice President of Quality & Regulatory Affairs at Elite. Scott brings more than 30 years of regulatory and quality experience in both the pharmaceutical brand and generic industry and includes extensive knowledge in regulations, quality systems, assessments, FDA submissions, compliance, and product applications for both oral solid dosages and sterile and non-sterile liquid products. In addition to six years of consulting in the pharmaceutical industry, Scott’s experience includes positions at Duramed, Pfizer, Schering-Plough and Warner Lambert. Scott received a Bachelor of Science in Chemistry from Western New England College.